BioSig Technologies, Inc. (Nasdaq: BSGM) (BioSig), a medical technology company, and Streamex Exchange Corporation (Streamex), a privately held company specializing in the tokenization of real-world assets, today announced they have signed a definitive share exchange agreement with a focus on bringing commodities on-chain.
The signing of the definitive agreement represents a major milestone for both Streamex and BioSig, propelling the business combination forward, and fast-tracking the growth of Streamex’s tokenization business. During this transaction, Streamex has made significant progress with some very exciting developments expected to be shared in the coming weeks.
Fasken advised Streamex with a team led by Mike M. Stephens (Information Technology) and Michael Coburn (Tax), and included Christopher Ross (Tax).
Jurisdiction
- British Columbia
